Efficacy of combining posterior scleral contraction and intravitreal CF injection in high myopia with macular hole retinal detachment.

AIM

To evaluate the efficacy and safety of combining posterior scleral contraction (PSC) with intravitreal perfluoropropane (CF) injection in high myopia with macular hole retinal detachment (MHRD).

METHODS

A total of 22 participants (22 eyes) with high myopia [axial length (AL)≥26.5 mm] and MHRD who underwent PSC combined with intravitreal CF injection, with at least 6mo of follow-up were retrospectively recruited. Outcome measures included best-corrected visual acuity (BCVA), AL, optical coherence tomography (OCT) findings, and adverse events. Retinal recovery was categorized as type I (macular hole bridging with retinal reattachment) or type II (reattachment without hole bridging).

RESULTS

The mean age of participants was 62.1±8.8y and mean follow-up duration was 9.18±4.21mo. Complete retinal reattachment was observed in 11 eyes (50%) at postoperative day 1, 19 eyes (86.3%) at week 1, and all 22 eyes at month 1. Ten eyes (45.5%) achieved type I recovery and 12 eyes (54.5%) achieved type II. Mean BCVA improved from 1.68±0.84 logMAR before surgery to 1.21±0.65 logMAR after surgery (<0.001), and AL was significantly reduced compared to baseline (29.07±2.05 30.8±2.2 mm; <0.001). No serious complications were reported.

CONCLUSION

PSC combined with intravitreal CF injection is a safe and effective treatment for MHRD in highly myopic eyes, especially for retinal detachment limited within the vascular arcade.